About
Judith Kelleher-Andersson, Ph.D., is the founder, President and CEO of Neuronascent, a biotech company developing small-molecule neuroregenerative therapeutics for Alzheimer's disease, Parkinson's disease and related neurological disorders. Company materials describe her as having more than 20 years of CNS drug-development experience and more than 70 patents. Public coverage shows her leading Neuronascent's grant-supported and investor-seeking clinical development efforts, especially around NNI-362.
Areas of interest
biotechneuroscienceCNS therapeuticsregenerative medicineAlzheimer's diseaseParkinson's diseaseneurodegenerationaging